Kotra Industries Bhd banner
K

Kotra Industries Bhd
KLSE:KOTRA

Watchlist Manager
Kotra Industries Bhd
KLSE:KOTRA
Watchlist
Price: 4.03 MYR Market Closed
Market Cap: 597.7m MYR

KOTRA's latest stock split occurred on Jul 5, 2007

The company executed a 196106-for-89139 stock split, meaning that for every 89139 shares held, investors received 196106 new shares.

Before the split, KOTRA traded at 1.89 per share. Afterward, the share price was about 0.6007.

The adjusted shares began trading on Jul 5, 2007. This was the only stock split in KOTRA's history.

Last Splits:
Jul 5, 2007
196106-for-89139
Pre-Split Price
0.5864 1.89
Post-Split Price
0.6007
Before
After
Last Splits:
Jul 5, 2007
196106-for-89139

Kotra Industries Bhd
Stock Splits History

KOTRA Stock Splits Timeline
Jul 5, 2007
Jul 5, 2007
Split 196106-for-89139
x2.2000022436868
Pre-Split Price
0.5864 1.89
Post-Split Price
0.6007
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 27, 2026
M
Mitsubishi Logisnext Co Ltd
TSE:7105
1-for-22962728
/22962728
1529 999999.9999 JPY N/A
Apr 27, 2026
Intsig Information Co Ltd
SSE:688615
1-for-1
x1
180.14 127.0214 CNY 128 128 CNY
Apr 27, 2026
Nousouken Corp
TSE:3541
1-for-550000
/550000
763 763 JPY N/A
Apr 27, 2026
F
Friendly Corp
TSE:8209
1-for-1355800
/1355800
312 999999.9999 JPY N/A
Apr 27, 2026
I
IA Inc
KOSDAQ:038880
1-for-10
/10
135 1350 KRW 1231 1231 KRW
Load More

Kotra Industries Bhd
Glance View

Market Cap
597.7m MYR
Industry
Pharmaceuticals

Kotra Industries Bhd.is an investment holding company, which engages in the manufacturing and trading of pharmaceutical and healthcare products. The company is headquartered in Malacca, Melaka and currently employs 660 full-time employees. The company went IPO on 2000-10-30. The Company, through its subsidiary, Kotra Pharma (M) Sdn. Bhd, is engaged in pharmaceutical and healthcare products manufacturing and trading business. Its segments include Malaysia, Asia and Africa. Its products include Appeton Multivitamin Pastilles, which is a healthy chewable pastille (non-sugar coated) for children; Axcel Glimepiride Medication, which is used to treat diabetes mellitus type 2; Axcel Bromhexine (Children) Syrup, which is a mucolytic medicine used in the treatment of respiratory chest congestion; Arite Beclometasone 50mcg (Metered Dose Inhaler Product), which is used in long-term management of asthma; Vaxcel Granisetron Injection, which is an antiemetic to treat nausea and vomiting following chemotherapy and radiotherapy, and Axcel Atenolol, which is used to treat high blood pressure and heart-associated chest pain.

KOTRA Intrinsic Value
4.16 MYR
Undervaluation 3%
Intrinsic Value
Price MYR4.03
K
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett